Seizure: European Journal of Epilepsy
Volume 19, Issue 4 , Pages 226-231 , May 2010

GABAB receptor activation exacerbates spontaneous spike-and-wave discharges in DBA/2J mice

  • Marco Bortolato

      Affiliations

    • Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, USA
    • Department of Neurological and Cardiovascular Sciences, University of Cagliari, Italy
    • Corresponding Author InformationCorresponding authors at: Department of Neurological and Cardiovascular Sciences, University of Cagliari, Policlinico Universitario, S.S. 554 Km 4.500, 09042 Monserrato (CA), Italy. Tel.: +39 070 51096191; fax: +39 070 51096032.
    • ,
  • Roberto Frau

      Affiliations

    • Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, USA
    • Department of Neuroscience Bernard B. Brodie, University of Cagliari, Italy
    • ,
  • Marco Orrù

      Affiliations

    • Department of Neuroscience Bernard B. Brodie, University of Cagliari, Italy
    • ,
  • Mauro Fà

      Affiliations

    • Department of Neuroscience Bernard B. Brodie, University of Cagliari, Italy
    • ,
  • Christian Dessì

      Affiliations

    • Department of Neuroscience Bernard B. Brodie, University of Cagliari, Italy
    • ,
  • Monica Puligheddu

      Affiliations

    • Department of Neurological and Cardiovascular Sciences, University of Cagliari, Italy
    • ,
  • Luigi Barberini

      Affiliations

    • Department of Neurological and Cardiovascular Sciences, University of Cagliari, Italy
    • ,
  • Giuliano Pillolla

      Affiliations

    • Department of Neuroscience Bernard B. Brodie, University of Cagliari, Italy
    • ,
  • Lorenzo Polizzi

      Affiliations

    • Department of Neurological and Cardiovascular Sciences, University of Cagliari, Italy
    • ,
  • Federico Santoni

      Affiliations

    • Department of Neurological and Cardiovascular Sciences, University of Cagliari, Italy
    • ,
  • Giampaolo Mereu

      Affiliations

    • Department of Experimental Biology and CNR Neuropsychopharmacology Section, University of Cagliari, Italy
    • ,
  • Francesco Marrosu

      Affiliations

    • Department of Neurological and Cardiovascular Sciences, University of Cagliari, Italy
    • Corresponding Author InformationCorresponding authors at: Department of Neurological and Cardiovascular Sciences, University of Cagliari, Policlinico Universitario, S.S. 554 Km 4.500, 09042 Monserrato (CA), Italy. Tel.: +39 070 51096191; fax: +39 070 51096032.

Received 18 July 2009 ,Revised 13 February 2010 ,Accepted 19 February 2010.

References 

  1. Commission on Classification and Terminology of the International League Against Epilepsy . Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989;30:389–399
  2. Panayiotopoulos CP. Typical absence seizures and their treatment. Arch Dis Child. 1999;81:351–355
  3. Manning J-PA, Douglas AR, Bowery NG. Pharmacology of absence epilepsy. Trends Pharmacol Sci. 2003;24:542–549
  4. Bortolato M, Frau R, Orru M, Piras AP, Fa M, Tuveri A, et al. Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice. Psychopharmacology. 2007;194:361–369
  5. Marrosu F, Santoni F, Fa M, Puligheddu M, Barberini L, Genugu F, et al. Beta and gamma range EEG power–spectrum correlation with spiking discharges in DBA/2J mice absence model: role of GABA receptors. Epilepsia. 2006;47:489–494
  6. Tan HO, Reid CA, Chiu C, Jones MV, Petrou S. Increased thalamic inhibition in the absence seizure prone DBA/2J mouse. Epilepsia. 2008;49:921–925
  7. Koek W, Carter LP, Wu H, Coop A, France CP. Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone. Behav Pharmacol. 2006;17:239–247
  8. Koek W, Mercer SL, Coop A. Cataleptic effects of gamma-hydroxybutyrate (GHB), its precursor gamma-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348. Psychopharmacology. 2007;192:407–414
  9. Koek W, Mercer SL, Coop A, France CP. Behavioral effects of gamma-hydroxybutyrate, its precursor gamma-butyrolactone, and GABA(B) receptor agonists: time course and differential antagonism by the GABA(B) receptor antagonist 3-aminopropyl(diethoxymethyl)phosphinic acid (CGP35348). J Pharmacol Exp Ther. 2009;330:876–883
  10. Crunelli V, Emri Z, Leresche N. Unravelling the brain targets of gamma-hydroxybutyric acid. Curr Opin Pharmacol. 2006;6:44–52
  11. Vergnes M, Marescaux C, Micheletti G, Depaulis A, Rumbach L, Warter JM. Enhancement of spike and wave discharges by GABAmimetic drugs in rats with spontaneous petit-mal-like epilepsy. Neurosci Lett. 1984;44:91–94
  12. Lettieri J, Fung HL. Improved pharmacological activity via pro-drug modification: comparative pharmacokinetics of sodium gammahydroxybutyrate and gamma-butyrolactone. Res Commun Chem Pathol Pharmacol. 1978;22:107–118
  13. Snead OC. The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges. Neuropharmacology. 1991;30:161–167
  14. Snead OC. Gamma-Hydroxybutyric acid-induced seizures bear no relation to core temperature. Epilepsia. 1990;31:253–258
  15. Gustaffson F. Determining the initial states in forward–backward filtering. IEEE Trans Signal Process. 1996;44:988–992
  16. Sevcik C. A procedure to estimate the fractal dimension of waveforms. Complexity Int. 1998;5
  17. Van Luijtelaar EL. Spike–wave discharges and sleep spindles in rats. Acta Neurobiol Exp (Wars.). 1997;57:113–121
  18. Marescaux C, Vergnes M, Depaulis A. Genetic absence epilepsy in rats from Strasbourg—a review. J Neural Transm Suppl. 1992;35:37–69
  19. Aizawa M, Ito Y, Fukuda H. Pharmacological profiles of generalized absence seizures in lethargic, stargazer and gamma-hydroxybutyrate treated model mice. Neurosci Res. 1997;29:17–22
  20. Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, et al. International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function. Pharmacol Rev. 2002;54:247–264
  21. Fassio A, Bonanno G, Cavazzani P, Raiteri M. Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABA-B receptor. Eur J Pharmacol. 1994;263:311–314
  22. Yamada K, Yu B, Gallagher JP. Different subtypes of GABAB receptors are present at pre- and postsynaptic sites within the rat dorsolateral septal nucleus. J Neurophysiol. 1999;(June (81)):2875–2883
  23. Princivalle AP, Richards DA, Duncan JS, Spreafico R, Bowery NG, et al. Modification of GABA(B1) and GABA(B2) receptor subunits in the somatosensory cerebral cortex and thalamus of rats with absence seizures (GAERS). Epilepsy Res. 2003;55:39–51
  24. Benke D, Honer M, Michel C, Bettler B, Mohler H. Gamma-aminobutyric acid type B receptor splice variant proteins GBR1a and GBR1b are both associated with GBR2 in situ and display differential regional and subcellular distribution. J Biol Chem. 1999;274:27323–27330
  25. Gervasi N, Monnier Z, Vincent P, Paupardin-Tritsch D, Hughes SW, Crunelli V, et al. Pathway-specific action of gammahydroxybutyric acid in sensory thalamus and its relevance to absence seizures. J Neurosci. 2003;23:11469–11478
  26. van Nieuwenhuijzen PS, McGregor IS, Hunt GE. The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen. Neuroscience. 2009;158:441–455
  27. Hosford DA, Lin FH, Kraemer DL, Cao Z, Wang Y, Wilson JT. Neural networks of structures in which GABA-B receptors regulate absence seizures in the lethargic (lh/lh) mouse model. J Neurosci. 1995;15:7367–7376
  28. Snead OC. The ontogeny of [3H]gamma-hydroxybutyrate and [3H]GABA-B binding sites: relation to the development of experimental absence seizures. Brain Res. 1994;659:147–156
  29. Koek W, France CP. Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists. Psychopharmacology. 2008;199:191–198
  30. Pumain R, Louvel J, Gastard M, Kurcewicz I, Vergnes M. Responses to N-methyl-d-aspartate are enhanced in rats with petit mal-like seizures. J Neural Transm Suppl. 1992;35:97–108
  31. Koerner C, Danober L, Boehrer A, Marescaux C, Vergnes M. Thalamic NMDA transmission in a genetic model of absence epilepsy in rats. Epilepsy Res. 1996;25:11–19
  32. van de Bovenkamp-Janssen MC, van der Kloet JC, van Luijtelaar G, Roubos EW. NMDA-NR1 and AMPA-GluR4 receptor subunit immunoreactivities in the absence epileptic WAG/Rij rat. Epilepsy Res. 2006;69:119–128
  33. Baarendse PJ, van Grootheest G, Jansen RF, Pieneman AW, Ogren SO, Verhage M, et al. Differential involvement of the dorsal hippocampus in passive avoidance in C57bl/6J and DBA/2J mice. Hippocampus. 2008;18:11–19
  34. Benavides J, Rumigny JF, Bourguignon JJ, Cash C, Wermuth CG, Mandel P, et al. High affinity binding sites for gamma-hydroxybutyric acid in rat brain. Life Sci. 1982;30:953–961
  35. Snead OC, Liu CC. Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem Pharmacol. 1984;15(33):2587–2590
  36. Hu RQ, Banerjee PK, Snead OC. Regulation of gamma-aminobutyric acid (GABA) release in cerebral cortex in the gamma-hydroxybutyric acid (GHB) model of absence seizures in rat. Neuropharmacology. 2000;39:427–439
  37. Palatini P, Tedeschi L, Frison G, Padrini R, Zordan R, Orlando R, et al. Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol. 1993;45:353–356
  38. Kaupmann K, Cryan JF, Wellendorph P, Mombereau C, Sansig G, Klebs K, et al. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci. 2003;18:2722–2730
  39. Carter LP, Wu H, Chen W, Matthews MM, Mehta AK, Hernandez RJ, et al. Novel gamma-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABA-B receptor agonists. J Pharmacol Exp Ther. 2005;313:1314–1323
  40. Snead OC. Antiabsence seizure activity of specific GABA-B and gamma-hydroxybutyric acid receptor antagonists. Pharmacol Biochem Behav. 1996;53:73–79
  41. Vergnes M, Boehrer A, Simler S, Bernasconi R, Marescaux C. Opposite effects of GABAB receptor antagonists on absences and convulsive seizures. Eur J Pharmacol. 1997;332:245–255
  42. Puigcerver A, van Luijtelaar EL, Drinkenburg WH, Coenen AL. Effects of the GABAB antagonist CGP 35348 on sleep–wake states, behaviour, and spike–wave discharges in old rats. Brain Res Bull. 1996;40:157–162
  43. Hosford DA, Clark S, Cao Z, Wilson WA, Lin FH, Morrisett RA, et al. The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice. Science. 1992;257:398–401
  44. Snead OC. Evidence for GABAB-mediated mechanisms in experimental generalized absence seizures. Eur J Pharmacol. 1992;31(213):343–349
  45. Marescaux C, Vergnes M, Liu Z, Depaulis A, Bernasconi R. GABAB receptor involvement in the control of genetic absence seizures in rats. Epilepsy Res Suppl. 1992;9:131–138
  46. Liu Z, Vergnes M, Depaulis A, Marescaux C. Involvement of intrathalamic GABAB neurotransmission in the control of absence seizures in the rat. Neuroscience. 1992;48:87–93

PII: S1059-1311(10)00049-X

doi: 10.1016/j.seizure.2010.02.007

Seizure: European Journal of Epilepsy
Volume 19, Issue 4 , Pages 226-231 , May 2010

Article Tools

* Image Usage & Resolution